Can-Fite BioPharma Ltd. (CANF)
NYSEAMERICAN: CANF · Real-Time Price · USD
3.000
-0.090 (-2.91%)
Apr 2, 2026, 10:43 AM EDT - Market open
Can-Fite BioPharma Market Cap
Can-Fite BioPharma has a market cap or net worth of $6.52 million as of April 2, 2026. Its market cap has decreased by -59.17% in one year.
Market Cap
6.52M
Enterprise Value
-2.04M
1-Year Change
-59.17%
Ranking
Category
Stock Price
$3.00
Market Cap Chart
Since November 3, 2008, Can-Fite BioPharma's market cap has decreased from $18.49M to $6.52M, a decrease of -64.76%. That is a compound annual growth rate of -5.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 31, 2026 | 6.52M | -73.56% |
| Dec 31, 2025 | 24.64M | 58.34% |
| Dec 31, 2024 | 15.56M | 75.98% |
| Dec 31, 2023 | 8.84M | -54.56% |
| Dec 29, 2022 | 19.46M | -49.59% |
| Dec 30, 2021 | 38.60M | 34.47% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| FibroBiologics | 4.46M |
| Moolec Science | 4.30M |
| Silexion Therapeutics | 4.26M |
| IO Biotech | 4.22M |
| Indaptus Therapeutics | 4.22M |
| Genprex | 4.20M |
| Alzamend Neuro | 4.03M |
| Azitra | 3.79M |